These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28805972)

  • 1. In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403.
    Ferrari F; Malfacini D; Journigan BV; Bird MF; Trapella C; Guerrini R; Lambert DG; Calo' G; Zaveri NT
    Pharmacol Res Perspect; 2017 Aug; 5(4):. PubMed ID: 28805972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations.
    Ferrari F; Cerlesi MC; Malfacini D; Asth L; Gavioli EC; Journigan BV; Kamakolanu UG; Meyer ME; Yasuda D; Polgar WE; Rizzi A; Guerrini R; Ruzza C; Zaveri NT; Calo G
    Eur J Pharmacol; 2016 Dec; 793():1-13. PubMed ID: 27780725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands.
    Asth L; Ruzza C; Malfacini D; Medeiros I; Guerrini R; Zaveri NT; Gavioli EC; Calo' G
    Neuropharmacology; 2016 Jun; 105():434-442. PubMed ID: 26867504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential In Vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G Protein and Beta-Arrestin Signaling at the Human Nociceptin Opioid Receptor.
    Lu JJ; Polgar WE; Mann A; Dasgupta P; Schulz S; Zaveri NT
    Mol Pharmacol; 2021 Jul; 100(1):7-18. PubMed ID: 33958480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist.
    Rizzi A; Cerlesi MC; Ruzza C; Malfacini D; Ferrari F; Bianco S; Costa T; Guerrini R; Trapella C; Calo' G
    Pharmacol Res Perspect; 2016 Aug; 4(4):e00247. PubMed ID: 28116100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2.
    Malfacini D; Ambrosio C; Gro' MC; Sbraccia M; Trapella C; Guerrini R; Bonora M; Pinton P; Costa T; Calo' G
    PLoS One; 2015; 10(8):e0132865. PubMed ID: 26248189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists.
    Azevedo Neto J; Ruzza C; Sturaro C; Malfacini D; Pacifico S; Zaveri NT; Calò G
    Front Neurosci; 2021; 15():657153. PubMed ID: 33859548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives.
    Rizzi A; Malfacini D; Cerlesi MC; Ruzza C; Marzola E; Bird MF; Rowbotham DJ; Salvadori S; Guerrini R; Lambert DG; Calo G
    Br J Pharmacol; 2014 Sep; 171(17):4138-53. PubMed ID: 24903280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040.
    Ferrari F; Rizzo S; Ruzza C; Calo G
    J Pharmacol Exp Ther; 2020 Apr; 373(1):34-43. PubMed ID: 31937563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120.
    Fischetti C; Rizzi A; Gavioli EC; Marzola G; Trapella C; Guerrini R; Petersen JS; Calo G
    Peptides; 2009 Feb; 30(2):248-55. PubMed ID: 18992780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt
    Cerlesi MC; Ding H; Bird MF; Kiguchi N; Ferrari F; Malfacini D; Rizzi A; Ruzza C; Lambert DG; Ko MC; Calo G; Guerrini R
    Eur J Pharmacol; 2017 Jan; 794():115-126. PubMed ID: 27871910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent.
    Hirao A; Imai A; Sugie Y; Yamada Y; Hayashi S; Toide K
    J Pharmacol Sci; 2008 Mar; 106(3):361-8. PubMed ID: 18319566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity.
    Shoblock JR
    CNS Drug Rev; 2007; 13(1):107-36. PubMed ID: 17461893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Assays for Investigating the NOP Receptor.
    Malfacini D; Caló G
    Handb Exp Pharmacol; 2019; 254():69-89. PubMed ID: 30725284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect.
    Ciccocioppo R; Cippitelli A; Economidou D; Fedeli A; Massi M
    Physiol Behav; 2004 Aug; 82(1):63-8. PubMed ID: 15234592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a novel NOP receptor agonist (SCH 225288) on guinea pig irritant-evoked, feline mechanically induced and canine infectious tracheobronchitis cough.
    McLeod RL; Tulshian DB; Ho GD; Fernandez X; Bolser DC; Parra LE; Zimmer JC; Erickson CH; Fawzi AB; Jayappa H; Lehr C; Erskine J; Smith-Torhan A; Zhang H; Hey JA
    Pharmacology; 2009; 84(3):153-61. PubMed ID: 19696521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOP-Targeted Nonpeptide Ligands.
    Zaveri NT; Meyer ME
    Handb Exp Pharmacol; 2019; 254():37-67. PubMed ID: 31119463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198).
    Chang SD; Brieaddy LE; Harvey JD; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA; Decker AM; McElhinny CJ; Zhong D; Peterson EE; Navarro HA; Bruchas MR; Carroll FI
    ACS Chem Neurosci; 2015 Dec; 6(12):1956-64. PubMed ID: 26367173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats.
    Economidou D; Fedeli A; Fardon RM; Weiss F; Massi M; Ciccocioppo R
    Peptides; 2006 Dec; 27(12):3299-306. PubMed ID: 17097763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.